198 related articles for article (PubMed ID: 35609012)
1. Risk of variant Creutzfeldt-Jakob disease transmission by blood transfusion in Australia.
McManus H; Seed CR; Hoad VC; Kiely P; Kaldor JM; Styles CE; Yang H; Law M; Gosbell IB
Vox Sang; 2022 Aug; 117(8):1016-1026. PubMed ID: 35609012
[TBL] [Abstract][Full Text] [Related]
2. Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks.
Pozzo di Borgo A; Rochette S; Gaussen A; O'Brien SF; Germain M; Renaud C; Lewin A
Transfus Med Rev; 2023 Jul; 37(3):150747. PubMed ID: 37827587
[TBL] [Abstract][Full Text] [Related]
3. Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies.
Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax EM; Keller AJ; Kaldor JM
Vox Sang; 2001 Jul; 81(1):6-11. PubMed ID: 11520409
[TBL] [Abstract][Full Text] [Related]
4. [Variant Creutzfeldt-Jakob disease in France: estimating the number of cases related to travel to the United Kingdom between 1980 and 1995].
Chadeau-Hyam M; Alpérovitch A
Rev Epidemiol Sante Publique; 2005 Feb; 53(1):15-24. PubMed ID: 15888987
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment for transmission of variant Creutzfeldt-Jakob disease by transfusion of red blood cells in the United States.
Yang H; Gregori L; Asher DM; Epstein JS; Anderson SA
Transfusion; 2014 Sep; 54(9):2194-201. PubMed ID: 24689837
[TBL] [Abstract][Full Text] [Related]
6. Removal of UK-donor deferral for variant Creutzfeldt-Jakob disease: A large donation gain in Australia.
Hoad VC; Seed CR; Kiely P; Styles CE; McManus H; Law M; Kaldor J; Gosbell IB
Vox Sang; 2023 Oct; 118(10):891-894. PubMed ID: 37563946
[TBL] [Abstract][Full Text] [Related]
7. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Peden AH; Ritchie DL; Ironside JW
Folia Neuropathol; 2005; 43(4):271-8. PubMed ID: 16416391
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
Hewitt PE; Llewelyn CA; Mackenzie J; Will RG
Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834
[TBL] [Abstract][Full Text] [Related]
9. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
Llewelyn CA; Hewitt PE; Knight RS; Amar K; Cousens S; Mackenzie J; Will RG
Lancet; 2004 Feb; 363(9407):417-21. PubMed ID: 14962520
[TBL] [Abstract][Full Text] [Related]
10. Geographic exposure risk of variant Creutzfeldt-Jakob disease in US blood donors: a risk-ranking model to evaluate alternative donor-deferral policies.
Yang H; Huang Y; Gregori L; Asher DM; Bui T; Forshee RA; Anderson SA
Transfusion; 2017 Apr; 57(4):924-932. PubMed ID: 28261810
[TBL] [Abstract][Full Text] [Related]
11. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US.
Ponte ML
PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547
[TBL] [Abstract][Full Text] [Related]
12. Low risk of variant Creutzfeldt-Jakob disease transmission from blood transfusions in Aotearoa New Zealand suggests donor exclusion policies can be relaxed.
Hayman DTS; Baker MG
N Z Med J; 2023 Aug; 136(1581):66-70. PubMed ID: 37619229
[TBL] [Abstract][Full Text] [Related]
13. Risk of variant Creutzfeldt-Jakob disease in a simulated cohort of Canadian blood donors.
Pozzo di Borgo A; Germain M; O'Brien SF; Delage G; Renaud C; Lewin A
Vox Sang; 2023 Sep; 118(9):738-745. PubMed ID: 37463691
[TBL] [Abstract][Full Text] [Related]
14. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
Urwin PJ; Mackenzie JM; Llewelyn CA; Will RG; Hewitt PE
Vox Sang; 2016 May; 110(4):310-6. PubMed ID: 26709606
[TBL] [Abstract][Full Text] [Related]
15. vCJD and blood transfusion in the United Kingdom.
Hewitt P
Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541
[TBL] [Abstract][Full Text] [Related]
16. Variant CJD and blood transfusion: are there additional cases?
Davidson LR; Llewelyn CA; Mackenzie JM; Hewitt PE; Will RG
Vox Sang; 2014 Oct; 107(3):220-5. PubMed ID: 24916465
[TBL] [Abstract][Full Text] [Related]
17. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
[TBL] [Abstract][Full Text] [Related]
18. Universal white blood cell reduction in Europe: has transmission of variant Creutzfeldt-Jakob disease been prevented?
Vamvakas EC
Transfus Med Rev; 2011 Apr; 25(2):133-44. PubMed ID: 21345641
[TBL] [Abstract][Full Text] [Related]
19. Variant Creutzfeldt-Jakob disease.
Will R
Folia Neuropathol; 2004; 42 Suppl A():77-83. PubMed ID: 15449462
[TBL] [Abstract][Full Text] [Related]
20. Risk of variant Creutzfeldt-Jakob disease in France.
Chadeau-Hyam M; Alpérovitch A
Int J Epidemiol; 2005 Feb; 34(1):46-52. PubMed ID: 15649960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
